ArticleInternational journal of molecular sciences2022

Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model.

Keerthi Kurma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.